Impact of distal embolization on myocardial perfusion and survival among patients undergoing primary angioplasty with glycoprotein IIb–IIIa inhibitors: insights from the EGYPT cooperation-Reference-Cited by-同舟云学术

Impact of distal embolization on myocardial perfusion and survival among patients undergoing primary angioplasty with glycoprotein IIb–IIIa inhibitors: insights from the EGYPT cooperation

Published:2009-11-17 Issue:1 Volume:30 Page:23-28
ISSN:0929-5305
Container-title:Journal of Thrombosis and Thrombolysis
language:en
Short-container-title:J Thromb Thrombolysis

Author:

De Luca Giuseppe,Gibson C. Michael,Bellandi Francesco,Noc Marko,Maioli Mauro,Zorman Simona,Zeymer Uwe,Gabriel H. Mesquita,Emre Ayse,Cutlip Donald,Arntz Hans-Richard,Dudek Dariusz,Rakowski Tomasz,Gyongyosi Maryann,Huber Kurt,van’t Hof Arnoud W. J.

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Hematology

Link

http://link.springer.com/content/pdf/10.1007/s11239-009-0419-y.pdf

Reference29 articles.

1. Zijlstra F, de Boer MJ, Hoorntje JC, Reiffers S, Reiber JH, Suryapranata H (1993) A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 328(10):680–684

2. Keeley EC, Boura JA, Grines CL (2003) Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 361:13–20

3. De Luca G, van’t Hof AW, Ottervanger JP, Hoorntje JC, Gosselink AT, Dambrink JH, Zijlstra F, de Boer MJ, Suryapranata H (2005) Unsuccessful reperfusion in patients with ST-segment elevation myocardial infarction treated by primary angioplasty. Am Heart J 150(3):557–562

4. Gibson CM (2003) Has my patient achieved adequate myocardial reperfusion? Circulation 108(5):504–507

5. Henriques JP, Zijlstra F, Ottervanger JP, de Boer MJ, van’t Hof AW, Hoorntje JC, Suryapranata H (2002) Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction. Eur Heart J 23(14):1112–1117

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current and Future Roles of Glycoprotein IIb–IIIa Inhibitors in Primary Angioplasty for ST-Segment Elevation Myocardial Infarction;Biomedicines;2024-09-04

2. Optimal strategy of primary percutaneous coronary intervention for acute myocardial infarction due to unprotected left main coronary artery occlusion (OPTIMAL): study protocol for a randomised controlled trial;Trials;2019-03-08

3. Recent Advances in Optimal Adjunctive Antithrombotic Therapy in STEMI Patients Undergoing Primary Angioplasty: An Overview;Current Vascular Pharmacology;2015-08-25

4. Platelet GP IIb-IIIa Receptor Antagonists in Primary Angioplasty: Back to the Future;Drugs;2015-07

5. Eosinophils count and periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions;Atherosclerosis;2014-09